Mexico Infectious Disease Point-of-care Testing Market (2026-2032) Outlook | Companies, Analysis, Revenue, Share, Size, Trends, Forecast, Industry, Growth & Value

Market Forecast By Applications (Tropical Disease, Liver Disease, Respiratory Disease, Sexual Disorders, Others), By Technologies (Lateral Flow, Flow-through, Agglutination Assays, Solid Phase), By End-users (Diagnostic Laboratories, Hospitals, Home-care Settings, Others) And Competitive Landscape
Product Code: ETC066682 Publication Date: Aug 2021 Updated Date: Jun 2026 Product Type: Report
Publisher: 6Wresearch Author: Ravi Bhandari No. of Pages: 70 No. of Figures: 35 No. of Tables: 5

Mexico Infectious Disease Point-of-care Testing Market Size, Share & Growth Rate

The Mexico Infectious Disease Point-of-care Testing Market was estimated at USD 98 Million in 2025 and is projected to reach USD 113 Million by 2032, growing at a CAGR of 2.1% from 2026 to 2032. This growth trajectory is primarily driven by the increasing demand for rapid and decentralized testing solutions, particularly in light of recent health crises. Furthermore, the Mexican government's efforts to enhance healthcare accessibility in underserved areas bolster the urgency for effective point-of-care testing.

Mexico Infectious Disease Point-of-care Testing Market Year-wise Growth Rate and Key Drivers

This graph highlights how the Mexico Infectious Disease Point-of-care Testing Market has steadily grown over the years, supported by major growth factors.

Mexico Infectious Disease Point-of-care Testing Market Year-wise Growth Rate and Key Drivers

The table below presents the year‑wise growth rates along with the key drivers influencing the market

YearGrowth RateMajor Drivers
2021-4.0%Increasing industrial infrastructure investments
20225.6%Expansion of transportation and logistics networks
20234.8%Increasing industrial infrastructure investments
20243.8%Expansion of transportation and logistics networks
20251.9%Increasing industrial automation investments
20261.0%Rapid growth in telecom and data center sectors
20272.1%Rising electricity demand across industries
20282.7%Increasing industrial automation investments
20292.4%Rapid growth in telecom and data center sectors
20302.9%Government infrastructure modernization initiatives
20313.0%Rapid growth in telecom and data center sectors
20322.9%Increasing industrial automation investments

Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.

Mexico Infectious Disease Point-of-care Testing Market Synopsis

The most significant force currently shaping the Mexico Infectious Disease Point-of-care Testing Market is the pressing need for swift diagnostic solutions. The demand for immediate, on-the-spot testing has surged as outbreaks become increasingly common, highlighting the limitations of traditional testing methods.

Government initiatives also play a pivotal role in this market, focusing on the development and deployment of point-of-care testing facilities. These efforts are designed to facilitate rapid diagnosis and treatment, ultimately leading to better management of infectious disease outbreaks across the nation.

Mexico Infectious Disease Point-of-care Testing Market Key Takeaways

  • The market is witnessing steady growth due to heightened demand for rapid testing solutions.
  • Government policies emphasize the need for improved accessibility to diagnostic services.
  • Technological advancements are enhancing the accuracy and speed of point-of-care testing devices.
  • Remote regions in Mexico remain under-tested, indicating significant opportunities for expansion.
  • Strategic collaborations between stakeholders are essential to address infrastructure challenges.

Evaluation of Restraints in Mexico Infectious Disease Point-of-care Testing Market

Despite its promising growth potential, the Mexico Infectious Disease Point-of-care Testing Market faces several constraints that impede its progress. Access to testing facilities remains limited, particularly in remote and rural areas, leading to delays in diagnosis and treatment. Furthermore, inadequate infrastructure and logistical hurdles exacerbate the difficulties associated with distributing point-of-care testing devices. As a result, fostering collaborations among healthcare providers, government entities, and technology firms is crucial to overcoming these obstacles and ensuring comprehensive testing availability throughout the country.

Mexico Infectious Disease Point-of-care Testing Market Trends

Current trends in the Mexico Infectious Disease Point-of-care Testing Market indicate a growing preference for integrated diagnostic platforms that facilitate multi-disease testing. Moreover, the adaptation of telehealth services is complementing point-of-care testing, allowing healthcare providers to interpret results in real time. Advances in digital health and artificial intelligence are also being harnessed to improve the accuracy and speed of diagnosis, further reshaping the market landscape.

Mexico Infectious Disease Point-of-care Testing Market Opportunities

Significant growth opportunities exist within the Mexico Infectious Disease Point-of-care Testing Market, especially in rural regions. Enhanced government funding and initiatives aimed at expanding healthcare infrastructure are creating an environment ripe for investment. Additionally, innovations in testing technology present avenues for differentiation, allowing manufacturers and providers to capture a larger share of this emerging market. The demand for localized and accessible healthcare solutions will continue to drive investments in this sector.

Government Initiatives in the Mexico Infectious Disease Point-of-care Testing Market

The Mexican government has implemented a series of public health policies that prioritize early detection and rapid response to infectious diseases. These initiatives aim to enhance accessibility to point-of-care testing facilities, particularly in remote areas, thus facilitating timely diagnosis and treatment. In addition, the government is actively collaborating with healthcare stakeholders to strengthen the infrastructure necessary for widespread testing, ensuring that the population is better equipped to manage outbreaks.

Future Insights of the Mexico Infectious Disease Point-of-care Testing Market

Looking ahead to 2026-2032, the Mexico Infectious Disease Point-of-care Testing Market is positioned for steady growth. The ongoing emphasis on rapid diagnostic capabilities, coupled with governmental support for healthcare improvements, is likely to sustain market momentum. As technological advancements continue to emerge, the market will increasingly adapt to incorporate new testing modalities, ensuring that the healthcare system can respond effectively to future infectious disease challenges.

Mexico Infectious Disease Point-of-care Testing Market Latest Developments (May 2025 - June 2026)

Recent developments in the Mexico Infectious Disease Point-of-care Testing Market highlight a surge in partnerships aimed at enhancing testing capabilities. Innovations in testing technology are being reported, focusing on increasing the speed and reliability of results. Additionally, there have been initiatives from various sectors to improve logistics and distribution networks for testing devices, addressing existing infrastructure challenges.

Mexico Infectious Disease Point-of-care Testing Market - Key Attractiveness of the Report

  • 10 Years of Market Numbers
  • Historical Data Starting from 2022 to 2025
  • Base Year: 2025
  • Forecast Data until 2032
  • Key Performance Indicators Impacting the Market
  • Major Upcoming Developments and Projects

Key Highlights of the Report:

  • Mexico Infectious Disease Point-of-care Testing Market Outlook
  • Market Size of Mexico Infectious Disease Point-of-care Testing Market, 2025
  • Forecast of Mexico Infectious Disease Point-of-care Testing Market, 2032
  • Historical Data and Forecast of Mexico Infectious Disease Point-of-care Testing Revenues & Volume for the Period 2022-2032F
  • Mexico Infectious Disease Point-of-care Testing Market Trend Evolution
  • Mexico Infectious Disease Point-of-care Testing Market Drivers and Challenges
  • Mexico Infectious Disease Point-of-care Testing Price Trends
  • Mexico Infectious Disease Point-of-care Testing Porter's Five Forces
  • Mexico Infectious Disease Point-of-care Testing Industry Life Cycle
  • Historical Data and Forecast of Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume By Applications for the Period 2022-2032F
  • Historical Data and Forecast of Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume By Tropical Disease for the Period 2022-2032F
  • Historical Data and Forecast of Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume By Liver Disease for the Period 2022-2032F
  • Historical Data and Forecast of Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume By Respiratory Disease for the Period 2022-2032F
  • Historical Data and Forecast of Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume By Sexual Disorders for the Period 2022-2032F
  • Historical Data and Forecast of Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume By Others for the Period 2022-2032F
  • Historical Data and Forecast of Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume By Technologies for the Period 2022-2032F
  • Historical Data and Forecast of Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume By Lateral Flow for the Period 2022-2032F
  • Historical Data and Forecast of Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume By Flow-through for the Period 2022-2032F
  • Historical Data and Forecast of Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume By Agglutination Assays for the Period 2022-2032F
  • Historical Data and Forecast of Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume By Solid Phase for the Period 2022-2032F
  • Historical Data and Forecast of Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume By End-users for the Period 2022-2032F
  • Historical Data and Forecast of Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume By Diagnostic Laboratories for the Period 2022-2032F
  • Historical Data and Forecast of Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume By Hospitals for the Period 2022-2032F
  • Historical Data and Forecast of Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume By Home-care Settings for the Period 2022-2032F
  • Historical Data and Forecast of Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume By Others for the Period 2022-2032F
  • Mexico Infectious Disease Point-of-care Testing Import Export Trade Statistics
  • Market Opportunity Assessment By Applications
  • Market Opportunity Assessment By Technologies
  • Market Opportunity Assessment By End-users
  • Mexico Infectious Disease Point-of-care Testing Top Companies Market Share
  • Mexico Infectious Disease Point-of-care Testing Competitive Benchmarking By Technical and Operational Parameters
  • Mexico Infectious Disease Point-of-care Testing Company Profiles
  • Mexico Infectious Disease Point-of-care Testing Key Strategic Recommendations

Mexico Infectious Disease Point-of-care Testing Market - Frequently Asked Questions

The market is projected to grow from USD 98 Million in 2025 to USD 113 Million by 2032, achieving a CAGR of 2.1% from 2026 to 2032.
Government policies are driving the establishment of point-of-care testing facilities, emphasizing early diagnosis and access, particularly in underserved areas, which is critical for managing infectious disease outbreaks.
The primary growth drivers include the increasing need for rapid diagnostic solutions and ongoing government initiatives aimed at improving healthcare access in remote regions.
The Mexico market grapples with limited access to testing facilities, particularly in rural areas, compounded by logistical and infrastructure issues that delay diagnosis and treatment.
Recent advancements in diagnostic technologies, including integrated platforms for multi-disease testing and digital health solutions, are reshaping the landscape, enabling faster and more accurate results.
6Wresearch actively monitors the Mexico Infectious Disease Point-of-care Testing Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the Mexico Infectious Disease Point-of-care Testing Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Mexico Infectious Disease Point-of-care Testing Market Overview

3.1 Mexico Country Macro Economic Indicators

3.2 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, 2022 & 2032F

3.3 Mexico Infectious Disease Point-of-care Testing Market - Industry Life Cycle

3.4 Mexico Infectious Disease Point-of-care Testing Market - Porter's Five Forces

3.5 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By Applications, 2022 & 2032F

3.6 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By Technologies, 2022 & 2032F

3.7 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By End-users, 2022 & 2032F

4 Mexico Infectious Disease Point-of-care Testing Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of infectious diseases in Mexico

4.2.2 Growing awareness about the benefits of point-of-care testing for infectious diseases

4.2.3 Government initiatives to improve healthcare infrastructure and accessibility

4.3 Market Restraints

4.3.1 Limited access to healthcare facilities in remote areas of Mexico

4.3.2 Lack of skilled healthcare professionals for conducting point-of-care testing

4.3.3 Stringent regulatory requirements for approval of point-of-care testing products

5 Mexico Infectious Disease Point-of-care Testing Market Trends

6 Mexico Infectious Disease Point-of-care Testing Market, By Types

6.1 Mexico Infectious Disease Point-of-care Testing Market, By Applications

6.1.1 Overview and Analysis

6.1.2 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Applications, 2022-2032F

6.1.3 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Tropical Disease, 2022-2032F

6.1.4 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Liver Disease, 2022-2032F

6.1.5 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Respiratory Disease, 2022-2032F

6.1.6 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Sexual Disorders, 2022-2032F

6.1.7 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Others, 2022-2032F

6.2 Mexico Infectious Disease Point-of-care Testing Market, By Technologies

6.2.1 Overview and Analysis

6.2.2 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Lateral Flow, 2022-2032F

6.2.3 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Flow-through, 2022-2032F

6.2.4 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Agglutination Assays, 2022-2032F

6.2.5 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Solid Phase, 2022-2032F

6.3 Mexico Infectious Disease Point-of-care Testing Market, By End-users

6.3.1 Overview and Analysis

6.3.2 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Diagnostic Laboratories, 2022-2032F

6.3.3 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Hospitals, 2022-2032F

6.3.4 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Home-care Settings, 2022-2032F

6.3.5 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Others, 2022-2032F

7 Mexico Infectious Disease Point-of-care Testing Market Import-Export Trade Statistics

7.1 Mexico Infectious Disease Point-of-care Testing Market Export to Major Countries

7.2 Mexico Infectious Disease Point-of-care Testing Market Imports from Major Countries

8 Mexico Infectious Disease Point-of-care Testing Market Key Performance Indicators

8.1 Adoption rate of point-of-care testing technologies in healthcare facilities

8.2 Percentage of infectious disease cases diagnosed using point-of-care testing

8.3 Number of training programs conducted to educate healthcare professionals on point-of-care testing techniques

9 Mexico Infectious Disease Point-of-care Testing Market - Opportunity Assessment

9.1 Mexico Infectious Disease Point-of-care Testing Market Opportunity Assessment, By Applications, 2022 & 2032F

9.2 Mexico Infectious Disease Point-of-care Testing Market Opportunity Assessment, By Technologies, 2022 & 2032F

9.3 Mexico Infectious Disease Point-of-care Testing Market Opportunity Assessment, By End-users, 2022 & 2032F

10 Mexico Infectious Disease Point-of-care Testing Market - Competitive Landscape

10.1 Mexico Infectious Disease Point-of-care Testing Market Revenue Share, By Companies, 2025

10.2 Mexico Infectious Disease Point-of-care Testing Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Global Go To Market Strategy - 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here
Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Leadership Perspectives from Industry Events

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Industry Events and Analyst Meet

Whitepaper

Read All